Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response

BACKGROUND/AIMS: Chronic infection with hepatitis C, genotype 2/3, responds better than other genotypes to peginterferon and ribavirin treatment. We hypothesized that a lower dose of peginterferon would be as effective, but less toxic than standard doses. METHODS: 30 patients were treated with low-d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: ROTMAN, Y., BORG, B. B., SOZA, A., FELD, J. J., MODI, A. A., LOOMBA, R., LUTCHMAN, G., RIVERA, E., DOO, E., GHANY, M. G., HELLER, T., NEUMANN, A. U., LIANG, T. J., HOOFNAGLE, J. H.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861161/
https://ncbi.nlm.nih.gov/pubmed/20163377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2010.04263.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars